Adverse pathologic features in T1/2 oral squamous cell carcinoma classified by the American Joint Committee on Cancer eighth edition and implications for treatment.

Narayana SubramaniamSamskruthi MurthyDeepak BalasubramanianTsu-Hui Hubert LowSivakumar VidhyadharanJonathan R ClarkKrishnakumar ThankappanSubramania Iyer

Published in: Head & neck (2018)

Incorporation of PNI and differentiation better reflect prognostic outcome in oral cavity tumors classified as T1 to T2 as per the new AJCC eighth edition. Increasing adverse pathological features resulted in worse survival.

Keyphrases

papillary thyroid
neoadjuvant chemotherapy
squamous cell
adverse drug
emergency department
locally advanced
radiation therapy
combination therapy
lymph node
replacement therapy
childhood cancer
electronic health record